600867.SS SHH
Tonghua Dongbao Pharmaceutical Co., Ltd.
1W: -0.1%
1M: -3.1%
3M: -5.2%
YTD: -11.4%
1Y: -6.8%
3Y: -17.2%
5Y: -24.9%
¥7.86 ($1.17)
+0.18 (+2.34%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$7.4B
-5.1% ▼
5Y CAGR: +6.6%
Total Liabilities
$978M
+76.2% ▲
5Y CAGR: +23.5%
Shareholders Equity
$6.4B
-11.5% ▼
5Y CAGR: +5.0%
Cash & Investments
$642M
-44.6% ▼
5Y CAGR: +11.8%
Total Debt
$697M
+364.4% ▲
5Y CAGR: +41.0%
Net Debt
$110M
+111.5% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $593M | $865M | $788M | $1.1B | $587M |
| Short-Term Investments | $150M | $37M | $58M | $56M | $55M |
| Cash & ST Investments | $744M | $902M | $847M | $1.2B | $642M |
| Net Receivables | $589M | $659M | $477M | $879M | $569M |
| Inventory | $538M | $538M | $654M | $705M | $736M |
| Other Current Assets | $69M | $72M | $100M | $38M | $0 |
| Total Current Assets | $1.9B | $2.2B | $2.1B | $2.8B | $2.0B |
| Property, Plant & Equip. | $2.3B | $2.4B | $2.7B | $2.7B | $2.7B |
| Goodwill & Intangibles | $609M | $797M | $1.1B | $1.3B | $1.6B |
| Long-Term Investments | $311M | $421M | $304M | $534M | $724M |
| Other Non-Current Assets | $635M | $706M | $596M | $340M | $130M |
| Total Non-Current Assets | $3.9B | $4.4B | $4.7B | $5.0B | $5.4B |
| Total Assets | $5.8B | $6.5B | $6.8B | $7.8B | $7.4B |
| — Liabilities — | |||||
| Accounts Payable | $68M | $75M | $81M | $116M | $97M |
| Short-Term Debt | $0 | $0 | $0 | $150M | $424M |
| Deferred Revenue | $8M | $8M | $21M | $0 | $16M |
| Other Current Liabilities | $140M | $194M | $81M | $10M | $128M |
| Total Current Liabilities | $208M | $269M | $162M | $520M | $665M |
| Long-Term Debt | $3M | $3M | $3M | $0 | $253M |
| Other Non-Current Liab. | $0 | $0 | $0 | $28M | $28M |
| Total Non-Current Liabilities | $36M | $31M | $39M | $35M | $313M |
| Total Liabilities | $244M | $300M | $201M | $555M | $978M |
| — Equity — | |||||
| Common Stock | $2.0B | $2.0B | $2.0B | $2.0B | $2.0B |
| Retained Earnings | $2.0B | $2.7B | $3.0B | $3.7B | $3.2B |
| Accumulated OCI | $863M | $1.0B | $1.2B | $5M | $1.1B |
| Total Stockholders Equity | $5.6B | $6.2B | $6.5B | $7.2B | $6.4B |
| Total Liabilities & Equity | $5.8B | $6.5B | $6.8B | $7.8B | $7.4B |
| — Key Metrics — | |||||
| Total Debt | $3M | $3M | $3M | $150M | $697M |
| Net Debt | -$591M | -$862M | -$785M | -$954M | $110M |
| Total Investments | $462M | $458M | $362M | $590M | $779M |